For one day tablet for one day obesity There may be a cheap and more Accessible weight loss drugA study found that the tablet may be “important” Body weight loss,
More than 60 percent of adults living in the UK are thick or overweight – a crisis that NHS is spending £ 107 billion per year.
Researchers found that out of about five people taking drugs in drug orflipron, it was reduced by 20 percent of their body weight after using it for about a year.
Although seen in people who lost weight Gun Shot It is not clear among patients as MounaroExperts believe that the tablet will be more accessible and convenient Compared with weight loss injection,
“This pill is easy to use and may be less expensive, it can allow more people to reach effective weight loss drugs and make the treatment of obesity simple and more convenient everywhere,” Dr. Stephen Lawrence, GP and Associate Clinical Professor at the University of Warwick said.
About 1.5 million people in Britain take drugs like silence, ozmpic and Vegovi To deal with conditions like obesity and diabetes.
Drugs known as GLP-1 agonist mainly treat diabetes, but are also available through NHS or private providers to help adults with high body mass index. Drugs are used mainly to control blood sugar levels, but they also reduce food deficiency and, as a result, can cause rapid weight loss.
Orforglipron tablet is also a GLP-1 agonist made by the pharmaceutical giant Elli Lily.
A snapshot of results was published by the company in August, and the full paper has now been published, expanding the findings. New England Journal of Medicine And was presented at the annual meeting of the European Association for the study of diabetes in Vienna, Austria.
In the study, 3,127 participants were divided into groups with obesity, taking different forces of weight loss pill, while others took a placebo for 72 weeks.
Patients from America, China, Brazil, India, Japan, South Korea, Spain, Slovakia and Taiwan participated in the study.
Researchers at McMaster University in Canada found that after 72 weeks, the lowest dosage of 6mg orforglipron lost 7.5 percent of their body weight.
The highest doses, a 36mg tablet, lost an average of 11.2 percent of its body weight.
Among the highest dosage patients, 54.6 percent of people had a decrease in body weight by 10 percent or more, 36 percent decreased by 15 percent or more, and 18.4 percent had a decrease of 20 percent or more.
People are taking Medicine In addition, there was a decrease in better blood pressure, a small waist circumference and poor cholesterol levels. He reported that the most common side effects were “light to moderate” gastrointestinal issues.
The authors wrote, “In adults with obesity, the 72-week treatment with orflipron caused a significant reduction in body weight compared to the placebo,” the authors wrote. “The adverse-phenomenon profile was in line with other GLP-1 receptor agonists.”
Dr. who led the research, Dr. Sean Wharton said: “This may mean expansion of obesity intervention for those groups that are currently excluded due to the cost and decrease of access to injected drugs.”
The weight loss jab has been awakened by health leaders as transformative. But injections come with additional work for overseased health services, so the tablet form of the drug, which is expected to be cheap and easy to use, can provide a new hope for millions of people to lose weight.
Eli Lily said that in August it was increasing the drug list by 170 percent after the pressure from Donald Trump, who said that he wanted to bring foreign prices on American drugs to the US costs.
The move has caused panic among many people, who already take the drug, expected to be forced to exit more than £ 100 every month with long -term users at high doses. However, the new bullet is expected to be cheaper.
ASDA Online Doctor Dr. Crystal Vayley said: “Taking a pill is more convenient for patients who struggle with needles, and also easy for health services.